Literature DB >> 28477749

Insights into dovetailing GTD and Cancers.

Revathy Nadhan1, Jayashree V Vaman2, Nirmala C3, Satheesh Kumar Sengodan1, Sreelatha Krishnakumar Hemalatha1, Arathi Rajan1, Geetu Rose Varghese1, Neetha Rl1, Amritha Krishna Bv1, Ratheeshkumar Thankappan1, Priya Srinivas4.   

Abstract

Gestational trophoblastic diseases (GTD) encompass a group of placental tumors which mostly arise due to certain fertilization defects, resulting in the over-proliferation of trophoblasts. The major characteristic of this diseased state is that β-hCG rises up manifold than that is observed during pregnancy. The incidence of GTD when analyzed on a global scale, figures out that there is a greater risk in South-East Asia, the reason of which remains unclear. An insight into any possible correlation of GTD incidence with cancers, other than choriocarcinoma, is being attempted here. Also, we review the recent developments in research on the molecular etiopathology of GTD. This review would render a wider eye towards a new paradigm of thoughts to connect GTD and breast cancer, which has not been into the picture till date.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cancers; GTD; Trophoblast; β-hCG

Mesh:

Year:  2017        PMID: 28477749     DOI: 10.1016/j.critrevonc.2017.04.001

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  9 in total

1.  Fatal cervix rupture due to intraplacental choriocarcinoma triggered by sexual intercourse.

Authors:  Huang Weisheng; Wu Shuang; Liang Yue; Tong Fang; Dong Hongmei; Zhou Yiwu
Journal:  Int J Legal Med       Date:  2019-11-07       Impact factor: 2.686

2.  BRCA1 promoter hypermethylation in human placenta: a hidden link with β-hCG expression.

Authors:  Revathy Nadhan; Jayashree Vijaya Vaman; Satheesh Kumar Sengodan; Sreelatha Krishnakumar Hemalatha; Nirmala Chellappan; Santha Sadasivan; Aysha Pasuthottiyil Varkey; Sreelekha Yesodharan; Krishnapriya Raji Sathyanpillai; Amritha Krishna Bhuvaneswari Venugopal; Sreevidya Prameelakumari Sreenivasan; Arathi Rajan; Neetha Rajan Latha; Geetu Rose Varghese; Ratheeshkumar Thankappan; Sarada Achyutuni; Jithin Dev Sreekumar Usha; Thapasimuthu Vijayamma Anilkumar; Priya Srinivas
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

3.  MST4 Regulates Epithelial-Mesenchymal Transition of Choriocarcinoma by Mediating TGF-β1 Expression.

Authors:  Hanxi Yu; Weichen Zhang; Peilin Han; Beng Yang; Xiaode Feng; Ping Zhou; Xiaoxu Zhu; Bingqian Zhou; Wei Chen; Jianhua Qian; Jun Yu
Journal:  Onco Targets Ther       Date:  2020-11-19       Impact factor: 4.147

4.  Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment.

Authors:  Baozhen Zhang; Guogang Cheng; Mingbin Zheng; Jinyu Han; Baobei Wang; Mengxia Li; Jie Chen; Tianxia Xiao; Jian Zhang; Lintao Cai; Shoujun Li; Xiujun Fan
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

Review 5.  Understanding and management of gestational trophoblastic disease.

Authors:  Fen Ning; Houmei Hou; Abraham N Morse; Gendie E Lash
Journal:  F1000Res       Date:  2019-04-10

6.  miR-30a targets STOX2 to increase cell proliferation and metastasis in hydatidiform moles via ERK, AKT, and P38 signaling pathways.

Authors:  Zhenzhen Guo; Chenyu Zhu; Ying Kong; Dong Li; Linlin Sui; Youhui Wang; Zhen Li; Lu Wang; Jianhui Fan; Yuefei Xu; Na Zou
Journal:  Cancer Cell Int       Date:  2022-03-04       Impact factor: 5.722

7.  Complete hydatidiform mole in a 52-year-old postmenopausal woman: A case report and literature review.

Authors:  Qin Wang; Hui Dong
Journal:  Case Rep Womens Health       Date:  2021-06-19

8.  Nucleoside transporter-guided cytarabine-conjugated liposomes for intracellular methotrexate delivery and cooperative choriocarcinoma therapy.

Authors:  Weidong Fei; Yunchun Zhao; Xiaodong Wu; Dongli Sun; Yao Yao; Fengmei Wang; Meng Zhang; Chaoqun Li; Jiale Qin; Caihong Zheng
Journal:  J Nanobiotechnology       Date:  2021-06-15       Impact factor: 10.435

9.  Angiogenin and MMP-2 as potential biomarkers in the differential diagnosis of gestational trophoblastic diseases.

Authors:  Dan Weng; Tao Han; Jin Dong; Ming Zhang; Yang Mi; Yiping He; Xiaojuan Li; Xiaoming Zhu
Journal:  Medicine (Baltimore)       Date:  2022-02-04       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.